Haoyang Xu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Landscape of splicing factors in early-onset gastric cancer reveals SRSF1 as a key driver of oxaliplatin resistance.
Journal: The Journal of biological chemistry
Published: November 05, 2025
Age-Stratified Clinicopathological Features and Efficacy of Adjuvant Chemotherapy in Resectable Gastric Cancer: An East-West Population-Based Study.
Journal: Current oncology (Toronto, Ont.)
Published: July 02, 2025
CDK12 inhibition enhances oxaliplatin efficacy in gastric cancer by suppressing the MAPK signaling pathway.
Journal: Journal of gastrointestinal oncology
Published: May 19, 2025
Kynurenine mediates the chemotherapy-induced intestinal toxicity through modulation of gut microbiota.
Journal: Nature communications
Published: March 12, 2025
Chemotherapy-induced microbiota exacerbates the toxicity of chemotherapy through the suppression of interleukin-10 from macrophages.
Journal: Gut microbes
Published: February 24, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026